Structural and functional characterization of the promoter regions of the NFKB2 gene
- PMID: 7541912
- PMCID: PMC307025
- DOI: 10.1093/nar/23.12.2328
Structural and functional characterization of the promoter regions of the NFKB2 gene
Abstract
In order to clarify the transcriptional regulation of the NFKB2 gene (lyt-10, NF-kappa Bp100), we have characterized the structure and function of its promoter regions. Based on the nucleotide sequence of cDNA clones and the 5' flanking genomic region of the NFKB2 gene, RT-PCR analysis in a number of human cell lines demonstrated the presence of two alternative noncoding first exons (1a and 1b). Two distinct promoter regions, P1 and P2, were identified upstream of each exon, containing multiple sites of transcription initiation, as shown by RNase protection analysis. Sequence analysis of these regions showed a CAAT box upstream of exon 1a and high G-C content regions within both P1 and P2. Consensus binding sites for transcription factors, including SP1, AP1 and putative NF-kappa B (kappa B sites), were found upstream of each exon. In particular, six kappa B sites were identified, all but one of them capable of binding NF-kappa B complexes in vitro. Transfection in HeLa cells of plasmids containing P1 and P2 sequences linked to a chloramphenicol acetyltransferase reporter gene indicated that both P1 and P2 can act independently as promoters. Co-transfection of NF-kappa B effector plasmids (NF-kappa Bp52 and RelA) with a reporter gene linked to P1 and P2 showed that the NFKB2 promoter regions are regulated by NF-kappa B factors. RelA transactivates the NFKB2 promoter in a dose-dependent manner, whereas NF-kappa Bp52 acts as a repressor, indicating that the NFKB2 gene may be under the control of a negative feedback regulatory circuit.
Similar articles
-
Dimerization of NF-KB2 with RelA(p65) regulates DNA binding, transcriptional activation, and inhibition by an I kappa B-alpha (MAD-3).Mol Cell Biol. 1993 Mar;13(3):1315-22. doi: 10.1128/mcb.13.3.1315-1322.1993. Mol Cell Biol. 1993. PMID: 8441377 Free PMC article.
-
Transcriptional regulation of human polyomavirus JC: evidence for a functional interaction between RelA (p65) and the Y-box-binding protein, YB-1.J Virol. 1996 Sep;70(9):5944-53. doi: 10.1128/JVI.70.9.5944-5953.1996. J Virol. 1996. PMID: 8709216 Free PMC article.
-
Interaction of an NF-kappa B-like factor with a site upstream of the c-myc promoter.Proc Natl Acad Sci U S A. 1990 Jun;87(12):4727-31. doi: 10.1073/pnas.87.12.4727. Proc Natl Acad Sci U S A. 1990. PMID: 2191300 Free PMC article.
-
The involvement of the candidate proto-oncogene NFKB2/lyt-10 in lymphoid malignancies.Leuk Lymphoma. 1996 Sep;23(1-2):43-8. doi: 10.3109/10428199609054800. Leuk Lymphoma. 1996. PMID: 9021684 Review.
-
Potential involvement of the transcription factor NF-kappa B in neurological disorders.Mol Aspects Med. 1993;14(3):171-90. doi: 10.1016/0098-2997(93)90004-w. Mol Aspects Med. 1993. PMID: 8264332 Review.
Cited by
-
Age-associated changes in basal NF-κB function in human CD4+ T lymphocytes via dysregulation of PI3 kinase.Aging (Albany NY). 2014 Nov;6(11):957-74. doi: 10.18632/aging.100705. Aging (Albany NY). 2014. PMID: 25553802 Free PMC article.
-
Inhibition of proliferation and survival of diffuse large B-cell lymphoma cells by a small-molecule inhibitor of the ubiquitin-conjugating enzyme Ubc13-Uev1A.Blood. 2012 Aug 23;120(8):1668-77. doi: 10.1182/blood-2012-02-406074. Epub 2012 Jul 12. Blood. 2012. PMID: 22791293 Free PMC article.
-
Temporal dynamics of a CSF1R signaling gene regulatory network involved in epilepsy.PLoS Comput Biol. 2021 Apr 5;17(4):e1008854. doi: 10.1371/journal.pcbi.1008854. eCollection 2021 Apr. PLoS Comput Biol. 2021. PMID: 33819288 Free PMC article.
-
Human Oncoprotein MDM2 Up-regulates Expression of NF-κB2 Precursor p100 Conferring a Survival Advantage to Lung Cells.Genes Cancer. 2011 Oct;2(10):943-55. doi: 10.1177/1947601911436008. Genes Cancer. 2011. PMID: 22701761 Free PMC article.
-
Deubiquitinating enzyme CYLD negatively regulates the ubiquitin-dependent kinase Tak1 and prevents abnormal T cell responses.J Exp Med. 2007 Jun 11;204(6):1475-85. doi: 10.1084/jem.20062694. Epub 2007 Jun 4. J Exp Med. 2007. PMID: 17548520 Free PMC article.
References
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous